Menu

Caribou Biosciences, Inc. CRBU

Full chart Compare
Set alert

Price alert · CRBU

All alert types
0.45 USD +0.04 (+8.83%)

At closeNov 9, 2026, 8:20 AM EST

0.44 -0.01 -1.49%

Pre-market · Nov 9, 8:20 AM ET

0.401 Day range 0.4487
0.401 52-week range 2.49
YTD
-71.78%
1 year
-79.03%

Revenue & Expenses

Income Tax Benefit → Expenses: $550.00KExpenses → Selling, General & Admin: $37.91MExpenses → Research & Development: $109.44MExpenses → Other Operating Expenses: $12.15MExpenses → Other Expenses: $331.00KGross Profit → Expenses: $11.16MRevenue → Gross Profit: $11.16MNet Loss → Expenses: $148.13MIncome Tax Benefit$550.00KGross Profit$11.16MNet Loss$148.13MExpenses$159.83MSelling, General & Admin$37.91MResearch & Development$109.44MOther Operating Expenses$12.15MOther Expenses$331.00KRevenue$11.16M

Latest period ending Dec 31, 2025 · select a line to chart its full history

CRBU annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
11.16M9.99M34.48M13.85M9.60M
11.16M9.99M34.48M13.85M9.60M
-148.34M-166.62M-116.06M-106.40M-66.98M
-148.13M-149.10M-102.07M-99.42M-66.92M
-1.59-1.65-1.38-1.64-2.11
CRBU annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
12.36M16.29M51.16M58.34M240.42M
175.37M313.31M432.21M373.76M442.36M
53.19M60.36M63.81M72.89M54.53M
27.23M26.49M27.11M27.75M0
122.17M252.95M368.40M300.87M387.82M
CRBU annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-110.99M-138.20M-93.29M-90.97M-32.52M
102.24M86.61M-68.18M-93.25M-176.40M
4.82M16.72M154.30M2.13M433.43M
-1.36M-4.87M-11.61M-6.45M-2.12M
-3.93M-34.87M-7.18M-182.08M224.51M